FMBH Q1 2026 Earnings Strong EPS Beat Fails to Boost Sentiment ZBIO Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Stage Blink Charging Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Surprise Amid Operational Adjustments ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains ESOA Q1 2026 Earnings EPS Surges Past Estimates with 743 Surprise One Liberty Properties OLP Edges Higher Modest Gain Amidst Sector Stability Biogen BIIB Posts 2 Gain as Stock Tests Resistance Near 207 Centuri Holdings Surges 374 Testing Key Resistance Near 33 KalVista Pharmaceuticals KALV Holds Steady Near Resistance as Investors Eye Key Catalysts RCT Q4 2025 Earnings Significant EPS Miss Amidst Limited Revenue Disclosure